Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) has been awarded £4.5 million to accelerate clinical research to prevent illness and deaths from epidemic infectious diseases.

ISARIC – whose Global Support Centre is hosted by the University of Oxford – is a world-wide, grass-roots consortium of clinical research networks, working together on epidemic infections such as pandemic influenza, Ebola, Lassa fever, and plague.

Read more (University of Oxford website)

Similar stories

AMR surveillance project in Nigeria delivers life-saving impacts

A research project led by the Ineos Oxford Institute for antimicrobial research (IOI) to study the cause and impact of antimicrobial-resistant sepsis in Nigeria has resulted in reduced new-born deaths, improved awareness about neonatal infection prevention amongst parents, and strengthened capacity and training for local doctors. The findings have been published in Nature Communications.